New York State Common Retirement Fund’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-31,363
Closed -$1.06M 3654
2021
Q2
$1.06M Buy
31,363
+2,063
+7% +$52.6K ﹤0.01% 2205
2021
Q1
$685K Hold
29,300
﹤0.01% 2298
2020
Q4
$844K Buy
29,300
+4,500
+18% +$113K ﹤0.01% 2115
2020
Q3
$502K Hold
24,800
﹤0.01% 2215
2020
Q2
$745K Buy
24,800
+11,200
+82% +$403K ﹤0.01% 2023
2020
Q1
$427K Sell
13,600
-2,200
-14% -$76.5K ﹤0.01% 2121
2019
Q4
$744K Hold
15,800
﹤0.01% 2095
2019
Q3
$102K Hold
15,800
﹤0.01% 3025
2019
Q2
$194K Buy
15,800
+14,300
+953% +$159K ﹤0.01% 2830
2019
Q1
$20K Hold
1,500
﹤0.01% 3132
2018
Q4
$6K Buy
+1,500
New +$9.04K ﹤0.01% 3180

New York State Common Retirement Fund's CNST Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 31,363 shares — an estimated $1.06M sold.

New York State Common Retirement Fund first reported a position in CNST in Q4 2018 and held it in 11 quarters. The position peaked at $1.06M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 31,363 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.06M.
  • New York State Common Retirement Fund first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2018 and held it in 11 quarters.
  • New York State Common Retirement Fund's Constellation Pharmaceuticals, Inc. position peaked at $1.06M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.